{{'Thu, 26 Jun 2025 11:09:00 -0400' | dateFormatUsFilter}}
Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety
Read more
{{'Mon, 23 Jun 2025 08:03:00 -0400' | dateFormatUsFilter}}
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
Read more
{{'Sun, 22 Jun 2025 15:35:00 -0400' | dateFormatUsFilter}}
Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.